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108 The Journal of Thoracic and Cardbjectives: Infants with right atrial isomerism have poor outcomes because of a
omplex combination of cardiac anomalies. Aggressive management of total anom-
lous pulmonary venous drainage might have a positive effect on the prognosis.
ethods: Outcomes of all children with right atrial isomerism from 1994 to the
resent were reviewed. Management of total anomalous pulmonary venous drainage
volved from no repair or conventional surgical technique to primary sutureless
epair on initial palliation. Cox survival models were used to identify variables
ssociated with reduced survival.
esults: There were 55 children enrolled in the study. The median age at the initial
isit was 2 days. Fifty-one patients had total anomalous pulmonary venous drainage
obstructive in 22 patients). Withdrawal of treatment occurred in 11 (20%) of 55
atients during an interval of institutional bias toward no treatment. Thirteen (24%)
f 55 patients had palliations without total anomalous pulmonary venous drainage
epair, and 3 (23%) of 13 survived. Thirty-one (56%) of 55 patients had operations
hat included total anomalous pulmonary venous drainage repair, of whom 13 (42%)
f 31 underwent primary sutureless repair for total anomalous pulmonary venous
rainage. Sixteen (52%) of 31 survived, and their current status 1 to 10 years
median, 5.8 years) after repair is post-Fontan (7/16 [44%]), postbidirectional Glenn
6/16 [38%]), and others (3 [20%]). In patients who underwent total anomalous
ulmonary venous drainage repair (n  31), 2 risk factors of decreased survival
ere identified: drainage site obstruction and infracardiac or mixed-type total anom-
lous pulmonary venous drainage. After adjustment, sutureless repair appeared to be
ssociated with improved survival (hazard ratio, 0.43), but this beneficial effect did
ot reach significance (P  .19).
onclusions: Mortality continues to be high; however, aggressive total anomalous
ulmonary venous drainage repair for right atrial isomerism has resulted in im-
roved survival. The role of primary sutureless repair for total anomalous pulmo-
ary venous drainage remains to be defined.
espite strategic and technical improvements in the treatment of complex
congenital heart anomalies, right atrial isomerism (RAI) associated with
abnormal pulmonary venous drainage has remained a clinical challenge
ith high early and late mortality.1,2 Discouraged by a number of clinical reports
nd by experiences of their own, some cardiac programs have been tempted to
ithdraw aggressive treatment from children with RAI, particularly when it is
ssociated with obstructive total anomalous pulmonary venous drainage (TAPVD).
reviously, we reported our 26-year experience of RAI between 1970 and 1996,
hich demonstrated that early mortality of RAI after palliative surgical procedures,
ncluding TAPVD repair, was as high as 95%. This disappointing experience led us
o have an institutional bias toward no treatment in this disease entity between 1998
iovascular Surgery ● May 2006
af
h
c
m
e
a
l
w
e
P
A
C
2
e
p
p
m
h
a
a
h
a
a
r
b
m
u
p
i
p
d
s
g
w
t
i
o
A
C
R
P
F
s
b
a
f
[
[
d
n
c
t
v
u
p
o
S
T
w
l
i
p
1
d
P
w
p
i
T
b
a
t
s
r
e
t
T
G
N
T
T
V
Yun et al Surgery for Congenital Heart Disease
CH
Dnd 1999. With the development of the sutureless technique
or TAPVD repair and extracorporeal life support systems,
owever, our institutional strategy has been changed from a
onventional treatment or treatment withdrawal to surgical
anagement, including primary sutureless repair of TAPVD,
xtracorporeal membrane oxygenation (ECMO)–ventricular
ssist device (VAD) support, and control of supraventricu-
ar tachyarrhythmias. In this study we sought to determine
hether these changes of therapeutic strategy had a positive
ffect on early and late outcome of RAI.
atients and Methods
review of children who registered at The Hospital for Sick
hildren, Toronto, Canada, between February 1994 and October
003 was performed. During this time, the treatment of RAI
volved from conventional management or withdrawal of care to
rimary sutureless repair of TAPVD with aggressive cardiac and
ulmonary support strategies (VAD and ECMO) if needed for
anagement of arrhythmia, ventricular dysfunction, or pulmonary
ypertension. The sutureless repair technique for pulmonary vein
nomalies, which was originally developed for the surgical man-
gement of pulmonary vein stenosis (PVS) after TAPVD repair,3
as been modified and adopted as a primary procedure for TAPVD
ssociated with RAI since 2000.4,5 For the retrospective review
nd collation of the data, “ethics approval of human subject health
ecord/database research” was obtained from the research ethical
oard in the hospital.
Data are presented as frequencies, medians with ranges, or
eans with standard deviations. Survival data are represented by
sing the Kaplan-Meier method. Stratified survival curves were
lotted to explore unadjusted group differences for variables of
nterest. After excluding the treatment withdrawal group, the Cox
roportional hazards model was fitted with time to death as the
ependent variable and stratified by indication categories (de-
cribed below) to allow different baseline hazards for each cate-
ory. Variables were selected by means of backward elimination
Abbreviations and Acronyms
AVSD  atrioventricular septal defect
BCPS  bidirectional cavopulmonary shunt
ECMO  extracorporeal membrane oxygenation
PVS  pulmonary vein stenosis
RAI  right atrial isomerism
TAPVD total anomalous pulmonary venous drainage
VAD  ventricular assist device
ABLE 1. Types of TAPVD (n  55)
roup No TAPVD Supracard
o treatment 0 5 (2)
APVD repair () 4 (0) 3 (1)
APVD repair () 0 19 (7)alues in parentheses represent draining site obstruction. TAPVD, Total anoma
The Journal of Thoracicith bootstrapping. The assumption of proportional hazards was
ested by using an interaction term between time and each variable
n the final model. The final model validation (to assess for
verfitting) and calibration were done by means of bootstrapping.
nalyses were conducted with S-plus 6.1 software (Insightful
orp).
esults
atients
ifty-five children with RAI were identified during the
tudy period. Age at the first visit ranged from the day of
irth to 6.5 years (median, 2 days). There were 34 male
nd 21 female patients. Associated anomalies were as
ollows: atrioventricular septal defect (AVSD; 45/55
82%]), TAPVD (51/55 [93%]; extracardiac types: 42/55
76%]), d-transposition of great arteries (16/55 [29%]),
ouble-outlet right ventricle (18/55 [33%]), pulmonary ste-
osis or atresia (45/55 [82%]), and bilateral superior vena
ava (16/55 [29%]). Ventricles were balanced in 20 pa-
ients, including balanced AVSD (18 patients) and normal
entricular morphology (2 patients). The ventricles were
nbalanced in 35 patients, including unbalanced AVSD (27
atients) and mitral or tricuspid atresia (8 patients). The type
f TAPVD is described in Table 1.
urgical Treatment
reatment withdrawal occurred in 11 (20%) of 55 children,
ith 6 withdrawals among 7 registered patients in 1998. The
ast treatment withdrawal in this reported group took place
n 2000. There has been no treatment withdrawal in the 17
atients from January 2001 through October 2003. In 10 of
1 treatment-withdrawal patients, death occurred between 1
ay and 3.6 months (median, 20 days) from progressive
VS, hypoxia, or both. One boy has survived 44.5 months
ithout any surgical intervention. Thirteen (14%) of 55
atients underwent various palliative operations that did not
nclude TAPVD repair. Thirty-one (56%) of 55 patients had
APVD repair, of which 18 were a standard anastomosis
etween the common pulmonary venous channel and atrium,
nd 13 were a primary sutureless repair. Palliative or correc-
ive procedures for the treatment group (44/55 patients) are
ummarized in Table 2. Four patients who had sutureless
epair for TAPVD received ECMO-VAD support postop-
ratively. Three patients were successfully removed from
he support without any neurologic complications and were
Cardiac Infracardiac Mixed
1 (0) 1 (1) 4 (3)
3 (0) 0 3 (0)
5 (4) 5 (3) 2 (1)iaclous venous drainage.
and Cardiovascular Surgery ● Volume 131, Number 5 1109
d
a
r
l
a
s
w
b
p
r
t
s
a
m
E
I
T
p
R
f
o
r
d
s
i
r
t
u
b
p
p
h
m
(
T
s
e
(
p
O
a
t
t
3
(
w
u
d
g
d
n
w
3
v
3
c
i
T
F
o
a
T
S
P
B
F
C
P
I
N
M
T
b
s
T
B
U
B
p
o
Surgery for Congenital Heart Disease Yun et al
1
CH
Discharged home. Of these, one child with supraventricular
rrhythmia associated with double atrioventricular nodes
eceived cryoablation in the critical care unit. Ablation of a
eft accessory atrioventricular node by using an epicardially
pplied cryoprobe controlled the medically unmanageable
upraventricular arrhythmia. On follow-up, 2 of 3 babies
ho survived ECMO-VAD support, including one who had
edside cryoablation in the intensive care unit, died unex-
ectedly at home at 4 and 6 months after initial palliation,
espectively. Autopsy was not done for these patients, and
he causes of death remain unknown. The third patient
urvived and underwent the Fontan operation at 20 months
fter initial repair. The relationship between ventricular
orphology and surgical strategies is described in Table 3.
arly and Late Outcome
n the 13 patients who had a palliative procedure without
APVD repair, 10 patients died 0 to 4.6 months after initial
alliation or after bidirectional cavopulmonary shunt (BCPS).
epair of pulmonary venous return was not initially per-
ormed because there was no abnormality (n  4) or the
bstruction was thought to be clinically manageable without
epair (n  1) or clinically insignificant (n  8). Causes of
eath were sudden hemodynamic instability in 5 patients,
epsis in 1 patient, progressive PVS in 1 patient, and unclear
ABLE 2. Operative procedures
Without TAPVD
repair
With TAPVD
repair
ystemic-pulmonary shunt 7 7
A banding 2 4
CPS 1 9
ontan operation 1 3
ardiac transplantation 0 2
A angioplasty 3 7
solated TAPVD repair 0 4
orwood operation 2 0
iscellaneous* 0 3
APVD, Total anomalous venous drainage; PA, pulmonary artery; BCPS,
idirectional cavopulmonary shunt. *Atrial switch operation (n  1), atrial
eptal defect closure (n  1), and subpulmonic resection (n  1).
ABLE 3. Ventricular morphology and surgical strategies
No
treatment BVR SVR HTx Undetermined*
alanced ventricles
(n  20) 2 2 5 1 10
nbalanced ventricles
(n  35) 9 0 16 1 9
VR, Biventricular repair; SVR, single-ventricle repair; HTx, heart trans-
lantation. *Operative death or treatment withdrawal before determinationmf surgical strategy.
110 The Journal of Thoracic and Cardiovascular Surgery ● Man 3 patients. In the 31 patients who underwent TAPVD
epair, 15 patients died after initial operations or subsequent
o BCPS, heart transplantation, or biventricular repair (Fig-
re 1). The cause of death was sudden hemodynamic insta-
ility in 6 patients, obstruction in the BCPS or Fontan
athway in 2 patients, progressive individual PVS in 2
atients, systemic thromboembolism in 1 patient, cerebral
emorrhage in 1 patient, and an unclear cause in the re-
aining 4 patients. Among the 16 patients who survived
16/31 [51.6%]), 3 patients had PVS (2 after conventional
APVD repair and 1 after sutureless repair), which neces-
itated secondary sutureless repair (n  2) or pulmonary
ndovenectomy (n  1). Their current status 1 to 10 years
median, 5.8 years) after repair is post-Fontan (7/16 [44%]),
ostbidirectional Glenn (6/16 [38%]), and others (3 [20%]).
verall survival and unadjusted survival according to age
t initial surgical intervention, TAPVD repair strategy, and
reatment-withdrawal strategy are shown in Figures 2
hrough 5. Patients who needed surgical intervention after
0 days of age (P  .0028), who underwent TAPVD repair
P  .036), and who registered in an era when no treatment
ithdrawal occurred (P  .0033) had better outcome by
nadjusted comparisons. In the cohort of patients who un-
erwent surgical intervention for TAPVD (n  31), 3
roups were identified. Group 1 had cardiac or supracar-
iac TAPVD without obstruction of the pulmonary ve-
ous drainage, group 2 had cardiac or supracardiac TAPVD
ith obstruction of pulmonary venous drainage, and group
had infracardiac or mixed-type TAPVD. Decreased sur-
ival was associated with group 2 versus group 1 and group
versus group 1. The hazard ratios of death were 5.53 (95%
onfidence interval, 1.15-26.63) and 16.51 (95% confidence
nterval, 2.81-97.21), respectively. The sutureless repair of
APVD appeared to show a trend for improved survival
igure 1. Outcome after treatment withdrawal, palliations with-
ut total anomalous pulmonary venous drainage (TAPVD) repair,
nd palliations with TAPVD repair. BCPS, Bidirectional cavopul-
onary shunt; Tx, transplantation; BVR, biventricular repair.
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Dhazard ratio, 0.43; 95% confidence interval, 0.12-1.52) but
id not reach statistical significance (P  .19).
iscussion
he outcome of RAI depends on the patient population
nrolled for the analysis. Early and late mortality after
idirectional cavopulmonary anastomosis or the Fontan op-
ration in patients with RAI are reasonably low and com-
arable with surgical outcomes in patients without RAI.6-9
his might be misleading because only selected patients
ho survived initial palliation were enrolled in those stud-
Figure 2. Survival after birth in all patients (n  55).
igure 3. Survival after birth for patients with first surgical inter-
ention after age 30 days (A), with first surgical intervention
uring the neonatal period (B), and with no treatment (C). Patients
ith neonatal surgical intervention had significantly worse prog-
osis than patients who had surgical intervention after 1 month of
ge (P  .0028), although the neonatal palliation group had better
utcome compared with the treatment-withdrawal group (P 
0406). d
The Journal of Thoracices. In contrast to the relatively favorable prognosis of left
trial isomerism,10-12 babies with RAI have a poor outcome.
he present data demonstrate that need for neonatal repair
nd the presence of pulmonary venous obstruction are risk
actors for mortality but also show that outcomes for those
reated are better than for those having treatment with-
rawal. Broad-category risk factors do not always explain
he reasons for the poor outcome. Some patients having an
natomically correct repair have sudden death, unexplained
nd-organ complications, or a protracted illness leading to
eath. Some have hemodynamically compromising su-
raventricular or ventricular arrhythmia after a surgical pro-
edure. Given the fact that withdrawal of treatment occurs
requently1,2 and surgical mortality after palliative proce-
ures is still high in patients with RAI, we developed a
igure 4. Survival after birth according to total anomalous pul-
onary venous drainage (TAPVD) repair strategy.
igure 5. Survival after birth according to treatment withdrawal
trategy. A, Survival in an era when all patients underwent
urgical treatment (from 2001); B, survival in an era when with-
rawal of treatment occurred in selected cases (before 2001).
and Cardiovascular Surgery ● Volume 131, Number 5 1111
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Dtrategy for operative and postoperative care that dealt with
ey issues.
ationale for VAD or ECMO Support
ne potential mechanism for sudden unexplained early death
fter neonatal repair for obstructed TAPVD is a profoundly
eactive pulmonary vasculature. In this situation a pulmo-
ary hypertensive crisis would have a self-compounding
ffect. Achieving a high pulmonary arterial saturation might
ot be possible where there is a balanced circulation. Hyp-
xia would induce further pulmonary hypertension, fol-
owed by further hypoxia and so forth. VAD and ECMO
upport the myocardium through a pulmonary hypertensive
risis and can be discontinued after a stabilization of pul-
onary reactivity. This rationale and strategy have been
seful in our patient cohort. Patients having severely com-
romising arrhythmia can also be maintained with adequate
xygenation and cardiac output until effective medical man-
gement of the arrhythmia is achieved. In one of our pa-
ients requiring VAD support for arrhythmia, we success-
ully performed cryoablation of a secondary atrioventricular
ode in the critical care. We have not used VAD-ECMO for
ll recent cases but believe it is a useful adjunct for the
bove-outlined reasons.
ationale for Primary Sutureless Pulmonary Vein
epair
uccessful early outcome for palliation of RAI might be
ompromised by late development of PVS. This has also
een noted with primary heart transplantation for RAI.13
child with pulmonary venous obstruction, regardless of
ause, in our institution undergoes a sutureless pulmonary
ein repair as a final attempt to treat the disease. We
ationalized that if infants with RAI were at high risk for
evelopment of pulmonary vein obstruction, then we should
erform the most aggressive surgical therapy for pulmonary
ein obstruction at the initial operation. This is based on the
ndings of others14-17 and our own findings1,18 that small
ize of the pulmonary vein is a major risk factor for later
evelopment of PVS after conventional TAPVD repair and
hat high mortality of RAI is related, at least in part, to
ntrinsically small pulmonary veins.1,14,16,18,19 Furthermore,
ost of the patients with RAI are not anatomic candidates
or biventricular repair. PVS is a risk factor for poor Fontan
peration outcome.7,9 The acute anatomic benefit for the
utureless repair is that each vein is its own native size,
ithout any suture material to cause an excessive inflam-
atory reaction or luminal compromise. Our findings of
elatively worse outcome for those not undergoing primary
epair of pulmonary venous abnormalities suggest that
ddressing any potentially obstructive pulmonary venous
nomaly at the first operation might be important.
Because primary sutureless repair for RAI is performed
ithout intrapericardial adhesion, longitudinal division of d
112 The Journal of Thoracic and Cardiovascular Surgery ● Mahe pulmonary veins into the pulmonary hilum might be
ssociated with violation of the thin pleura at the junction
etween the parietal and visceral pleura overlying the pul-
onary hilum and left atrial bleeding into the pleural space.
his can be managed by means of reapproximation of the
arietal and visceral pleura with a fine running suture to
chieve hemostasis.4 Given that the rationale for primary
utureless repair of the pulmonary vein in RAI is the small
ize of the confluent pulmonary vein rather than the indi-
idual PVS, excessive division of the extrapericardial por-
ion of the pulmonary veins is generally unnecessary. There-
ore it should be avoided in the first instance.
ingle and Biventricular Repair
hose with balanced ventricles might present a challenge
or biventricular repair because of a combined AVSD20-26
nd conotruncal anomaly.1,27 Clinical reports of biventricu-
ar repair for RAI have been rare and sporadic.27-30 A
eonate with obstructed TAPVD, an AVSD, double-outlet
ight ventricle with the aorta distant from the ventricular
eptal defect, and pulmonary atresia might not ever be
hought to be amenable to a biventricular repair, despite
alanced ventricles. However, in view of the present find-
ngs, along with current trends toward biventricular re-
air for various congenital anomalies (eg, marginally
ypoplastic left heart syndrome, unbalanced AVSD, and
ongenitally corrected transposition of the great arteries),
t might be rational to shift the competing risks of TAPVD
nd complex intracardiac repair versus TAPVD and single-
entricle repair more to the biventricular repair side of the
isk analysis. Because there were 20 children with balanced
entricles in our series, it is conceivable that biventricular
epair might have been achievable in some of them.
imitations of the Study
he small number of patients with RAI and specifically the
mall numbers undergoing a sutureless repair for TAPVD
nd ECMO-VAD support make the statistical strength of
he analysis weak. The potential for the sutureless pulmo-
ary vein repair to improve early and late outcome of RAI
n terms of the prevention of postrepair PVS cannot be
tatistically shown. On the basis of favorable findings in an
nalysis of development of PVS, for all patients after a
utureless repair,4 there is some reason to believe that the
utureless technique might be beneficial for patients with
AI and pulmonary venous abnormalities. Generalized
mprovements in knowledge, expertise, and delivery of peri-
perative care are difficult to quantify but might, neverthe-
ess, also contribute to improved outcomes. Improved out-
omes in RAI might therefore be multifactorial. In this
egard ECMO-VAD and antiarrhythmia surgery were ad-
ressed as new therapeutic strategies for critically ill babies
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Dith RAI in this article. Any beneficial or detrimental effect
as not statistically significant.
onclusions
utcomes for RAI continue to be less than optimal, partic-
larly when there is infracardiac or mixed TAPVD with
raining site obstruction, presentation requiring repair in the
eonatal period, or both. A strategy for primary sutureless
epair of the pulmonary venous anomaly and aggressive use
f ECMO-VAD support until the pulmonary vascular reac-
ivity, arrhythmia, or both have subsided appears to be
eneficial. Other unmeasured improvements in care might
lso be contributory. Primary sutureless repair of the pul-
onary veins has been associated with a low incidence of
evelopment of subsequent pulmonary venous obstruction.
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